Electrophysiological characterization of a Cav3.2 calcium channel missense variant associated with epilepsy and hearing loss
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem
PubMed
37735453
PubMed Central
PMC10515227
DOI
10.1186/s13041-023-01058-2
PII: 10.1186/s13041-023-01058-2
Knihovny.cz E-zdroje
- Klíčová slova
- CACNA1H, Calcium channels, Cav3.2, Channelopathy, Epilepsy, Hearing, Ion channels, Mutation, T-type channels,
- MeSH
- epilepsie * genetika MeSH
- lidé MeSH
- missense mutace genetika MeSH
- mutace genetika MeSH
- nedoslýchavost * MeSH
- vápníkové kanály MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
- Názvy látek
- vápníkové kanály MeSH
T-type calcium channelopathies encompass a group of human disorders either caused or exacerbated by mutations in the genes encoding different T-type calcium channels. Recently, a new heterozygous missense mutation in the CACNA1H gene that encodes the Cav3.2 T-type calcium channel was reported in a patient presenting with epilepsy and hearing loss-apparently the first CACNA1H mutation to be associated with a sensorineural hearing condition. This mutation leads to the substitution of an arginine at position 132 with a histidine (R132H) in the proximal extracellular end of the second transmembrane helix of Cav3.2. In this study, we report the electrophysiological characterization of this new variant using whole-cell patch clamp recordings in tsA-201 cells. Our data reveal minor gating alterations of the channel evidenced by a mild increase of the T-type current density and slower recovery from inactivation, as well as an enhanced sensitivity of the channel to external pH change. To what extend these biophysical changes and pH sensitivity alterations induced by the R132H mutation contribute to the observed pathogenicity remains an open question that will necessitate the analysis of additional CACNA1H variants associated with the same pathologies.
Department of Pathophysiology 3rd Faculty of Medicine Charles University Prague Czech Republic
Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences Prague Czech Republic
Nantes Université CNRS INSERM l'Institut du Thorax Nantes France
Zobrazit více v PubMed
Weiss N, Zamponi GW. Genetic T-type calcium channelopathies. J Med Genet. 2020;57(1):1–10. doi: 10.1136/jmedgenet-2019-106163. PubMed DOI PMC
Daniil G, Fernandes-Rosa FL, Chemin J, Blesneac I, Beltrand J, Polak M, et al. CACNA1H mutations are associated with different forms of primary aldosteronism. EBioMedicine. 2016;13:225–236. doi: 10.1016/j.ebiom.2016.10.002. PubMed DOI PMC
Splawski I, Yoo DS, Stotz SC, Cherry A, Clapham DE, Keating MT. CACNA1H mutations in autism spectrum disorders. J Biol Chem. 2006;281(31):22085–22091. doi: 10.1074/jbc.M603316200. PubMed DOI
Viggiano M, D’Andrea T, Cameli C, Posar A, Visconti P, Scaduto MC, et al. Contribution of CACNA1H variants in autism spectrum disorder susceptibility. Front Psychiatry. 2022;13:858238. doi: 10.3389/fpsyt.2022.858238. PubMed DOI PMC
Rzhepetskyy Y, Lazniewska J, Blesneac I, Pamphlett R, Weiss N. CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing. Channels (Austin) 2016;10(6):466–477. doi: 10.1080/19336950.2016.1204497. PubMed DOI PMC
Stringer RN, Jurkovicova-Tarabova B, Huang S, Haji-Ghassemi O, Idoux R, Liashenko A, et al. A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Cav3.2 T-type channel activity. Mol Brain. 2020;13(1):33. doi: 10.1186/s13041-020-00577-6. PubMed DOI PMC
Carter MT, McMillan HJ, Tomin A, Weiss N. Compound heterozygous CACNA1H mutations associated with severe congenital amyotrophy. Channels (Austin) 2019;13(1):153–161. doi: 10.1080/19336950.2019.1614415. PubMed DOI PMC
Gambeta E, Gandini MA, Souza IA, Zamponi GW. CaV3.2 calcium channels contribute to trigeminal neuralgia. Pain. 2022;163:2315. doi: 10.1097/j.pain.0000000000002651. PubMed DOI
Mustafá ER, Gambeta E, Stringer RN, Souza IA, Zamponi GW, Weiss N. Electrophysiological and computational analysis of Cav3.2 channel variants associated with familial trigeminal neuralgia. Mol Brain. 2022;15(1):91. doi: 10.1186/s13041-022-00978-9. PubMed DOI PMC
Algahtani HA, Shirah BH, Samman A, Alhazmi A. Epilepsy and hearing loss in a patient with a rare heterozygous variant in the CACNA1H gene. J Epilepsy Res. 2022;12(1):33–35. doi: 10.14581/jer.22006. PubMed DOI PMC
Delisle BP, Satin J. pH modification of human T-type calcium channel gating. Biophys J. 2000;78(4):1895–1905. doi: 10.1016/S0006-3495(00)76738-5. PubMed DOI PMC
Maksemous N, Blayney CD, Sutherland HG, Smith RA, Lea RA, Tran KN, et al. Investigation of CACNA1I Cav3.3 Dysfunction in Hemiplegic Migraine. Front Mol Neurosci. 2022;15:892820. doi: 10.3389/fnmol.2022.892820. PubMed DOI PMC
Lundt A, Seidel R, Soós J, Henseler C, Müller R, Bakki M, et al. Cav3.2 T-type calcium channels are physiologically mandatory for the auditory system. Neuroscience. 2019;409:81–100. doi: 10.1016/j.neuroscience.2019.04.024. PubMed DOI
Lei D, Gao X, Perez P, Ohlemiller KK, Chen CC, Campbell KP, et al. Anti-epileptic drugs delay age-related loss of spiral ganglion neurons via T-type calcium channel. Hear Res. 2011;278(1–2):106–112. doi: 10.1016/j.heares.2011.05.010. PubMed DOI PMC
Ay E, Gurses E, Aslan F, Gulhan B, Alniacik A, Duzova A et al. Hearing loss related to gene mutations in distal renal tubular acidosis. Audiol Neurootol. 2023;1–10. PubMed
de Curtis M, Manfridi A, Biella G. Activity-dependent pH shifts and periodic recurrence of spontaneous interictal spikes in a model of focal epileptogenesis. J Neurosci. 1998;18:7543–7551. doi: 10.1523/JNEUROSCI.18-18-07543.1998. PubMed DOI PMC
Schuchmann S, Schmitz D, Rivera C, Vanhatalo S, Salmen B, Mackie K, et al. Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosis. Nat Med. 2006;12(7):817–823. doi: 10.1038/nm1422. PubMed DOI PMC
Helmy MM, Tolner EA, Vanhatalo S, Voipio J, Kaila K. Brain alkalosis causes birth asphyxia seizures, suggesting therapeutic strategy. Ann Neurol. 2011;69(3):493–500. doi: 10.1002/ana.22223. PubMed DOI
Lu D, Ji Y, Sundaram P, Traub RD, Guan Y, Zhou J, et al. Alkaline brain pH shift in rodent lithium-pilocarpine model of epilepsy with chronic seizures. Brain Res. 2021;1758:147345. doi: 10.1016/j.brainres.2021.147345. PubMed DOI PMC
Schuchmann S, Hauck S, Henning S, Grüters-Kieslich A, Vanhatalo S, Schmitz D, et al. Respiratory alkalosis in children with febrile seizures. Epilepsia. 2011;52(11):1949–1955. doi: 10.1111/j.1528-1167.2011.03259.x. PubMed DOI